BN-005

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBN-005
Drug Alias Nameosteoblast regulators (Bone Medical)BN-005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOsteoblasts inhibitors
TargetsUpdating
Therapy Area/IndicationsArthritisOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBotanix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBotanix Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsArthritisOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A